1Hirama M, Takahashi F, Takahashi K, et al. Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth. Cancer Lett, 2003, 198(1): 107-117. 被引量：1
2Zhang J, Takahashi K, Takahashi F, et al. Diferential osteopontin expression in lung cancer. Cancer Lett, 2001, 17(2): 215-222. 被引量：1
3Shijubo N, Uede T, Kon S, et al. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma. AmJ Respir Crit Care Med, 1999, 160(4): 1269-1273. 被引量：1
5Ikehara M, Oshita F, Kameda Y, et al. Expression of Survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung. Oncol Rep, 2002, 9(4): 835-838. 被引量：1
9Shibuya M, Claesson -WelshL. Signal transductionby VEGF receptors in regulation of angioge nesis and lymphangioge -nesis. Exp Cell Res, 2006, 312(5): 549-556. 被引量：1
10Gerber HP, Malik AK, Solar GP, et al. VEGF regulates hae-matopoietic stem cell survival by aninternal autocrine loop mechanism. Nature, 2002, 417(6892): 954-958. 被引量：1
7Wu Y, Denhardt DT, Rittling SR. Osteopontin is required for full expression of the transformed phenotype by the ras oncogene[J].Br J Cancer, 2000, 83(2): 156-163. 被引量：1
8Hirama M, Takahashi F, Takahashi K, et al. Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth [J]. Cancer Lett, 2003, 198 (1): 107-117. 被引量：1
9Zhang J, Takahashi K, Takahashi F, et al. Differential osteopontin expression in lung cancer [J]. Cancer Lett, 2001, 17 (2): 215-222. 被引量：1
10Shijubo N, Uede T, Kon S, et al. Vascular endothelial growth factor and osteopontin in stage 1 lung adenocarcinoma [J]. Am J Respir Crit Care Med, 1999, 160(4): 1269-1273. 被引量：1
